Monday, September 14, 2026

Radiopharmaceuticals Revolution: How Novartis’s 1.4 Billion USD Investment Transforms Cancer Treatment in South Korea

A 140 billion KRW investment by Novartis aims to enhance the radioactive pharmaceutical industry, focusing on precision medicine and Theranostics.

How the New U.S. Investment Special Law Could Shield South Korea from Tariff Threats

Kim Sang-hoon predicts the U.S. Investment Special Act will stabilize tariffs, enhancing investment and cooperation between Korea and the U.S.

Tag: Nyongbyon

No posts to display

Top News

- Our Sponsors Ad -

Follow us